Elke A. Jarboe,
MD
Languages Spoken: English
Dr. Jarboe is a staff pathologist at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. She received her MD from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women's Hospital in Boston. Dr. Jarboe is a member of several professional societies, including the United States and Canadian Academy of Pathology, American Association for Cancer Research, American Society for Clinical Pathology, and College of American Pathologists.
Dr. Jarboe's primary subspecialty and research interest is in gynecologic pathology.
Specialties
Board Certification and Academic Information
| Academic Departments | Pathology
-
Associate Professor Obstetrics/Gynecology - Adjunct Assistant Professor |
| Academic Divisions | Anatomic Pathology Gynecologic Oncology |
| Board Certification | National Board of Medical Examiners |
Dr. Jarboe is a staff pathologist at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. She received her MD from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women's Hospital in Boston. Dr. Jarboe is a member of several professional societies, including the United States and Canadian Academy of Pathology, American Association for Cancer Research, American Society for Clinical Pathology, and College of American Pathologists.
Dr. Jarboe's primary subspecialty and research interest is in gynecologic pathology.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Pathology
-
Associate Professor Obstetrics/Gynecology - Adjunct Assistant Professor |
| Academic Divisions | Anatomic Pathology Gynecologic Oncology |
| Board Certification | National Board of Medical Examiners |
Education History
| Fellowship | Brigham and Women's Hospital Cytopathology Fellow, 2008 |
| Fellowship | Brigham and Women's Hospital Gynecological Surgical Pathology Fellow, 2007 |
| Residency | University of Colorado School of Medicine Pathology Resident, 2006 |
| Internship | University of Colorado School of Medicine Pathology Intern, 2004 |
| Professional Medical | University of Colorado School of Medicine Medicine M.D., 2003 |
| Fellowship | University of Colorado School of Medicine Academic Fellow, 2001 |
| Graduate Training | Colorado State University Microbiology Master's, 1999 |
| Undergraduate | Colorado State University Microbiology B.S., 1995 |
Selected Publications - Journal Articles
Journal Article
- Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250.
- Vahrenkamp JM, Szczotka K, Dodson MK, Jarboe EA, Soisson AP, Gertz J (2019). FFPEcap-seq: a method for sequencing capped RNAs in formalin-fixed paraffin-embedded samples. Genome Res, 29(11), 1826-1835.
- Dillon C, Rezvani M, McLean H, Adelman M, Dassel M, Jarboe E, Jant-Amsbury M, Payne A (2019). A tissue preparation to characterize uterine fibroid tissue properties for thermal therapies. Med Phys, 46(8), 3344-3355.
- Baniak N, Fadare O, Kbel M, DeCoteau J, Parkash V, Hecht JL, Hanley KZ, Gwin K, Zheng W, Quick CM, Jarboe EA, Liang SX, Kinloch M (2018). Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon. Am J Surg Pathol, 43(4), 531-537.
- Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Rawish KR, Roma AA, Zheng W, Hecht JL, Parkash V, Osunkoya AO (2017). Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases. Int J Gynecol Pathol, 37(6), 525-535.
- Vahrenkamp JM, Yang CH, Rodriguez AC, Almomen A, Berrett KC, Trujillo AN, Guillen KP, Welm BE, Jarboe EA, Janat-Amsbury MM, Gertz J (2017). Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer. Cell Rep, 22(11), 2995-3005.
- Taurin S, Yang CH, Reyes M, Cho S, Coombs DM, Jarboe EA, Werner TL, Peterson CM, Jant-Amsbury MM (2017). Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model. Int J Gynecol Cancer, 28(1), 152-160.
- Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, Muto MG, Tworoger S, Crum CP (2008). A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol, 109(2), 168-73.
- Jarboe EA, Folkins AK, Nucci MR, Kindelberger D, Drapkin R, Miron A, Lee Y, Crum CP (2008). Serous Carcinogenesis in the Fallopian Tube (SCAT): A Descriptive Classification. Int J Gynecol Pathol, 27(1), 1-9.
- Jarboe EA, Thompson LC, Heinz D, McGregor JA, Shroyer KR (2004). Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Hum Pathol, 35(4), 396-402.
Review
Book Chapter
- Jarboe EA, Folkins A, Callahan MJ, Crum CP (2008). Pathology of BRCA-Associated Ovarian Cancers, Including Occult Cancers. In Lu KH (Ed.), Hereditary Gynecologic Cancer: Risk, Prevention, and Management (pp. 29-44). Informa Healthcare.